MIDAZOLAM , ODM-208 100 mg Tablet, ODM-208 50 mg Tablet, ODM-208 25 mg Tablet, ODM-208 5 mg film-coated tablet
3124001
Phase 2 small_molecule active
Quick answer
MIDAZOLAM , ODM-208 100 mg Tablet, ODM-208 50 mg Tablet, ODM-208 25 mg Tablet, ODM-208 5 mg film-coated tablet for Metastatic castration-resistant prostate cancer. is a Phase 2 program (small_molecule) at Orion with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Orion
- Indication
- Metastatic castration-resistant prostate cancer.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active